
Loading, please wait...

Loading, please wait...

Axillary lymph node dissection is a critical procedure for many breast cancer patients undergoing surgical treatment. However, this surgical intervention carries a significant lifetime risk of developing lymphedema. This condition, known as breast cancer-related lymphedema (BCRL), affects approximately 20-30% of patients. During a mastectomy, surgeons may perform the dissection through the primary mastectomy incision or a separate axillary incision. Historically, clinicians have debated whether a separate incision causes more lymphatic disruption, potentially increasing lymphedema rates.
A recent retrospective study by Wang J et al. analyzed 1,036 patients to determine if the incision site impacts BCRL outcomes. The researchers compared 483 patients who received a separate axillary incision to 553 patients who underwent dissection through the mastectomy incision. The results indicated that separate axillary incisions do not increase lymphedema rates. Specifically, the lymphedema rate was 29% for the separate incision group versus 30% for the mastectomy incision group. Moreover, the difference between these cohorts was not statistically significant, with a p-value of 0.77.
Multivariable logistical regression further supported these clinical findings. Specifically, the analysis showed that patients undergoing axillary lymph node dissection via a separate incision did not have significantly greater odds of developing swelling (OR 0.89). Consequently, surgeons can choose the incision site based on oncologic safety and technical accessibility rather than fear of lymphedema. Furthermore, the median time to lymphedema development was 15 months, suggesting that long-term monitoring is essential regardless of the incision type used. In addition, prioritizing the thoroughness of lymph node retrieval remains the most important factor for oncologic success.
No, research indicates that performing the dissection through a separate incision does not significantly increase the risk of lymphedema compared to using the mastectomy incision.
While the incision type is not a major factor, significant risk factors include a high body mass index (BMI), regional lymph node radiation, and the total number of lymph nodes removed during the procedure.
The median time to development is approximately 15 months, though it can occur at any time during a patient\'s life following axillary lymph node dissection.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
1. Wang J et al. Axillary Lymph Node Dissection Through a Separate Incision Does Not Increase Rates of Breast Cancer-Related Lymphedema. Ann Surg Oncol. 2026 Feb 10. doi: 10.1245/s10434-026-19215-x. PMID: 41665789.
2. Lindqvist EK, et al. Risk factors for lymphedema after breast cancer treatment. Lymphatic Research and Biology. 2022.
3. National Cancer Institute. Lymphedema (PDQ®)–Health Professional Version. 2024.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study of 1,036 patients found that performing axillary lymph node dissection through a separate incision does not increase lymphedema risk....
6 months ago

A landmark study reveals that Milk Fat Globule-EGF Factor 8 (MFG-E8) protects hepatocytes from ferroptotic death and preserves epithelial integrity during liver injury, highlighting novel therapeutic targets for hepatic regeneration and acute liver failure management.
Today

A prospective study evaluates the fetal Evans Index in late-onset fetal growth restriction, uncovering anterior cerebral remodeling rather than ventriculomegaly, with conventional growth metrics retaining primary prognostic power for neonatal intensive care unit admission.
Today

Following the admission of Union Health Minister JP Nadda to AIIMS Delhi for acute uneasiness, clinical teams utilized diagnostic coronary angiography and inpatient observation. This clinical review outlines acute triage pathways, procedural protocols, post-procedure observation, and long-term risk management.
Today

Recent research assesses an automated pipeline for CT-based vertebral finite element analysis, revealing how boundary condition components—especially load-point assignment—impact fracture-load accuracy in spinal biomechanics.
Today

Diabetic kidney disease remains a major cause of renal failure despite renin-angiotensin system blockade. Learn how combining SGLT2 inhibitors, nonsteroidal MRAs, GLP-1 receptor agonists, and novel aldosterone synthase or endothelin inhibitors addresses residual cardiorenal risk.
Today